Vesparum
Highly Engaged Employees
Finance · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
180 Flinders St L 4, Melbourne, Victoria...Phone Number
+61 385824800Website
www.vesparum.comRevenue
<$5 MillionIndustry
About Vesparum
Vesparum Org Chart
Is Vesparum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vesparum recently announced quarterly report
Product Launch: Get notified when Vesparum launches new products
Congratulate Masked Content for being promoted to Masked Content at Vesparum
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vesparum had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Vesparum has new funding data
Check out if Vesparum is spiking on competitors!
Vesparum, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Vesparum has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Vesparum as Masked Content
Find 2 more new buyers
Compare Similar Companies to Vesparum
Compare insights from companies similar to Vesparum, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vesparum is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Vesparum is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Vesparum.
Vesparum Tech Stack
A closer look at the technologies used by Vesparum
Vesparum News & Media
Orthocell Secures New Patent for Suture-Less Repair of Soft Tissue
PERTH, Australia--(BUSINESS WIRE)--Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it has been granted a further Australian patent for its CelGro® collagen medical device platform for soft tissue regeneration and repair applications. The patent entitled “Suture-less repair of soft tissue” provides additional important intellectual property to protect the CelGro® product platform. Orthocell Managing Director Paul Anderson said: “This
Top Finance Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Vesparum
Vesparum is an independent capital raising advisor specializing in growth-stage, founder-led Australian technology businesses. They focus on assisting companies at Series A, Series B, and Growth Equity stages, primarily in the tech sector. Their services include primary capital raisings, acquisition funding, and shareholder sell-downs, with a commi... Read More